Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Enterprise Value: 2009-2024

Historic Enterprise Value for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Dec 2024 value amounting to $620.4 million.

  • Ironwood Pharmaceuticals' Enterprise Value fell 87.30% to $72.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$217.5 million, marking a year-over-year decrease of 186.76%. This contributed to the annual value of $620.4 million for FY2024, which is 63.38% down from last year.
  • According to the latest figures from FY2024, Ironwood Pharmaceuticals' Enterprise Value is $620.4 million, which was down 63.38% from $1.7 billion recorded in FY2023.
  • Ironwood Pharmaceuticals' Enterprise Value's 5-year high stood at $1.7 billion during FY2023, with a 5-year trough of $620.4 million in FY2024.
  • For the 3-year period, Ironwood Pharmaceuticals' Enterprise Value averaged around $1.2 billion, with its median value being $1.2 billion (2022).
  • As far as peak fluctuations go, Ironwood Pharmaceuticals' Enterprise Value surged by 36.27% in 2023, and later crashed by 63.38% in 2024.
  • Yearly analysis of 5 years shows Ironwood Pharmaceuticals' Enterprise Value stood at $1.2 billion in 2020, then grew by 7.06% to $1.3 billion in 2021, then declined by 3.39% to $1.2 billion in 2022, then skyrocketed by 36.27% to $1.7 billion in 2023, then slumped by 63.38% to $620.4 million in 2024.